Posted by Michael Wonder on 09 Feb 2022
Angelini Pharma’s Ontozry available for patients in Scotland with drug resistant epilepsy
9 February 2022 - SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy
New hope, however, has been offered to adults in Scotland with uncontrolled focal epilepsy, as the SMC has accepted Ontozry (cenobamate) for adults with drug resistant epilepsy.
